Gp350-anchored extracellular vesicles: promising vehicles for delivering therapeutic drugs of B cell malignancies
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmaceutical Science,Pharmacology
Reference45 articles.
1. Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies;Gill;Immunol Rev,2015
2. CAR T-cell therapy in hematological malignancies;Haslauer;Int J Mol Sci,2021
3. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia;Brentjens;Sci Transl Med,2013
4. Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia;Dai;J Hematol Oncol,2020
5. CAR19/22 T cell therapy in adult refractory Burkitt's lymphoma;Zhou;Cancer Immunol Immunother,2021
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nature’s carriers: leveraging extracellular vesicles for targeted drug delivery;Drug Delivery;2024-06-04
2. An ex vivo model of interactions between extracellular vesicles and peripheral mononuclear blood cells in whole blood;Journal of Extracellular Vesicles;2023-12
3. Cellular organelles as drug carriers for disease treatment;Journal of Controlled Release;2023-11
4. Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment;Frontiers in Immunology;2023-09-26
5. Beyond Extracellular Vesicles: Hybrid Membrane Nanovesicles as Emerging Advanced Tools for Biomedical Applications;Advanced Science;2023-09-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3